Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01818427 · ClinicalTrials.gov registry record · Phase 3

PreHospital Air Medical Plasma Trial

A Phase 3 study, sponsored by Jason Sperry.

Completed
Registry status
Phase 3
Development phase
523
Enrollment target

NCT01818427: Completed Phase 3 study, sponsored by Jason Sperry.

NCT01818427 is a Phase 3 study that has completed, run by Jason Sperry. The registered enrollment target is 523 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01818427, a Phase 3 study, has completed, sponsored by Jason Sperry.

COMPLETED
Registry status
Phase 3
Development phase
523 participants
Enrollment target

Study Summary

To determine the effect of the prehospital infusion during air transport of 2 units of AB plasma on 30 day mortality in patients with hemorrhagic shock as compared to conventional care.

Primary Outcome

All cause 30 day mortality using imputation for those with missing 30 day mortality.

Interventions

  • BIOLOGICAL infusion of 2 units of plasma

Trial Details

FieldValue
Enrollment Target 523 participants
Start Date 2014-05
Est. Completion 2017-09
Phase Phase 3
Jason Sperry

10 total trials

What the finished NCT01818427 record still lists

NCT01818427 is an interventional study that assigns participants to a tested intervention. The registered 523 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (32% lower).

The record links to 0 conditions, and to 1 intervention - of which infusion of 2 units of plasma is the first listed.

NCT01818427 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01818427 about?

NCT01818427 is a clinical study titled "PreHospital Air Medical Plasma Trial". To determine the effect of the prehospital infusion during air transport of 2 units of AB plasma on 30 day mortality in patients with hemorrhagic shock as compared to conventional care.

What is the current status of trial NCT01818427?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 523 participants. The study started on 2014-05. Estimated completion is 2017-09.

What interventions are being tested in trial NCT01818427?

The interventions under investigation include: infusion of 2 units of plasma (BIOLOGICAL).

Who is sponsoring clinical trial NCT01818427?

This trial is sponsored by Jason Sperry, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01818427's enrollment target sits among peer trials

523 716th of 2000 higher than 1,285 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03526835 · 523 participants · Phase 1

    A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  • NCT04580134 · 524 participants · Phase 4

    CLOZAPINE Response in Biotype-1

  • NCT07158814 · 524 participants · Phase 4

    Safety of RSV Preventive Monoclonal Antibody

  • NCT06835686 · 522 participants · NA

    Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01818427, the US trial registry maintained by the National Library of Medicine. NCT01818427 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.